Sign In
Buy ZVSA
ZyVersa Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 8.57M and sold 0 ZVSA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
100.00 |
| ● Buy | 8.57M shares |
| ● Sell | 0 shares |
|
100% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Dec 12, 2022 Buy |
Guzman Pablo A. Chief Medical Officer |
9 015 Value: $62.2K |
||
|
Dec 12, 2022 Buy |
Guzman Pablo A. Chief Medical Officer |
9 015 Value: $62.2K |
||
|
Dec 12, 2022 Buy |
Incon Co., Ltd. Director |
1 497 199 Value: $0 |
||
|
Dec 12, 2022 Buy |
Incon Co., Ltd. Director |
450 702 Value: $0 |
||
|
Dec 12, 2022 Buy |
Incon Co., Ltd. Director |
1 497 199 Value: $0 |
||
|
Dec 12, 2022 Buy |
Incon Co., Ltd. Director |
450 702 Value: $0 |
||
|
Dec 12, 2022 Buy |
Finizio Robert G Director |
29 781 Value: $0 |
||
|
Dec 12, 2022 Buy |
Finizio Robert G Director |
19 854 Value: $0 |
||
|
Dec 12, 2022 Buy |
Finizio Robert G Director |
9 927 Value: $0 |
||
|
Dec 12, 2022 Buy |
Wolfe Peter Chief Financial Officer |
41 585 Value: $0 |
||
|
Dec 12, 2022 Buy |
Wolfe Peter Chief Financial Officer |
39 708 Value: $0 |
||
|
Dec 12, 2022 Buy |
Wolfe Peter Chief Financial Officer |
21 840 Value: $0 |
||
|
Dec 12, 2022 Buy |
Wolfe Peter Chief Financial Officer |
18 058 Value: $0 |
||
|
Dec 12, 2022 Buy |
Wolfe Peter Chief Financial Officer |
11 763 Value: $0 |
||
|
Dec 12, 2022 Buy |
Wolfe Peter Chief Financial Officer |
9 927 Value: $0 |
||
|
Dec 12, 2022 Buy |
Park Min-chul Director |
29 781 Value: $0 |
||
|
Dec 12, 2022 Buy |
Park Min-chul Director |
9 927 Value: $0 |
||
|
Dec 12, 2022 Buy |
Labella Nicholas A. Jr. Chief Scientific Officer |
59 563 Value: $0 |
||
|
Dec 12, 2022 Buy |
Labella Nicholas A. Jr. Chief Scientific Officer |
39 709 Value: $0 |
||
|
Dec 12, 2022 Buy |
Labella Nicholas A. Jr. Chief Scientific Officer |
39 708 Value: $0 |
||
|
Dec 12, 2022 Buy |
Labella Nicholas A. Jr. Chief Scientific Officer |
29 781 Value: $0 |
||
|
Dec 12, 2022 Buy |
Labella Nicholas A. Jr. Chief Scientific Officer |
19 854 Value: $0 |
||
|
Dec 12, 2022 Buy |
Labella Nicholas A. Jr. Chief Scientific Officer |
18 094 Value: $0 |
||
|
Dec 12, 2022 Buy |
Cashmere Karen A. Chief Commercial Officer |
29 781 Value: $0 |
||
|
Dec 12, 2022 Buy |
Cashmere Karen A. Chief Commercial Officer |
21 840 Value: $0 |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
